Lihong Bu

1.6k total citations
28 papers, 1.1k citations indexed

About

Lihong Bu is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Lihong Bu has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 9 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Lihong Bu's work include Renal Diseases and Glomerulopathies (11 papers), Phytoestrogen effects and research (7 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Lihong Bu is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Phytoestrogen effects and research (7 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Lihong Bu collaborates with scholars based in United States, Canada and France. Lihong Bu's co-authors include Edwin D. Lephart, Christopher A. Walsh, Zhaohui Jin, Trent D Lund, Xianhua Piao, Steven M. Greenberg, Hannah C. Kinney, Ona Wu, David M. Greer and Emi Takahashi and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Kidney International.

In The Last Decade

Lihong Bu

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lihong Bu United States 12 282 194 181 178 135 28 1.1k
Ralph Plehm Germany 24 685 2.4× 79 0.4× 238 1.3× 68 0.4× 100 0.7× 37 2.6k
Yangmei Chen China 22 365 1.3× 28 0.1× 289 1.6× 158 0.9× 175 1.3× 99 1.4k
E Pedersen Denmark 19 153 0.5× 117 0.6× 171 0.9× 38 0.2× 59 0.4× 73 1.0k
Johann Gross Germany 19 303 1.1× 19 0.1× 99 0.5× 94 0.5× 54 0.4× 60 1.2k
Yasushi Miyagi Japan 22 163 0.6× 87 0.4× 463 2.6× 95 0.5× 93 0.7× 88 1.4k
Isao Araki Japan 29 378 1.3× 161 0.8× 279 1.5× 43 0.2× 388 2.9× 110 2.3k
Gerald Ponath Germany 25 620 2.2× 251 1.3× 158 0.9× 51 0.3× 93 0.7× 32 1.9k
Kenjiro Tanaka Japan 23 395 1.4× 69 0.4× 158 0.9× 25 0.1× 75 0.6× 133 1.7k
Elise Belaïdi France 23 656 2.3× 197 1.0× 74 0.4× 75 0.4× 297 2.2× 61 1.8k
Kyoung‐Gyu Choi South Korea 16 486 1.7× 39 0.2× 353 2.0× 49 0.3× 84 0.6× 36 1.4k

Countries citing papers authored by Lihong Bu

Since Specialization
Citations

This map shows the geographic impact of Lihong Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihong Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihong Bu more than expected).

Fields of papers citing papers by Lihong Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihong Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihong Bu. The network helps show where Lihong Bu may publish in the future.

Co-authorship network of co-authors of Lihong Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Lihong Bu. A scholar is included among the top collaborators of Lihong Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihong Bu. Lihong Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasr, Samih H., Tiffany Caza, Christopher P. Larsen, et al.. (2025). Dual-antigen membranous nephropathy. Kidney International. 109(1). 217–224.
2.
Bu, Lihong, Samar M. Said, Yi Zhu, Loren Herrera Hernandez, & Samih H. Nasr. (2025). 1477 The Characteristics of IgM Variant of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits. Laboratory Investigation. 105(3). 103717–103717. 1 indexed citations
3.
Bu, Lihong, Anthony M. Valeri, Samar M. Said, et al.. (2025). IgM Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Series. American Journal of Kidney Diseases. 85(6). 716–726.e1. 1 indexed citations
4.
Kalantari, Kambiz, Loren P. Herrera Hernandez, Lihong Bu, et al.. (2024). Acute kidney injury, an underrecognized feature of VEXAS syndrome. Lara D. Veeken. 64(4). 2027–2033. 3 indexed citations
5.
Nasr, Samih H., Satoru Kudose, Anthony M. Valeri, et al.. (2024). Clinicopathologic Characteristics of Crystalglobulin-Induced Nephropathy: A Case Series. American Journal of Kidney Diseases. 84(6). 708–718.e1.
6.
Caza, Tiffany, Laurence H. Beck, Jason Misurac, et al.. (2023). Clinical and Histopathologic Characteristics of Pediatric Patients With Primary Membranous Nephropathy. Kidney International Reports. 8(11). 2368–2375. 2 indexed citations
7.
Kudose, Satoru, L. Nicholas Cossey, Pietro A. Canetta, et al.. (2023). Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy. Kidney International Reports. 8(8). 1585–1595. 10 indexed citations
8.
Bu, Lihong, Samar M. Said, Loren Herrera Hernandez, et al.. (2023). The Characteristics of Concurrent Anti-Glomerular Basement Membrane Nephritis and Membranous Nephropathy. Kidney International Reports. 8(10). 2164–2167. 5 indexed citations
9.
Freese, Rebecca, Virginie Royal, Lihong Bu, et al.. (2022). Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy. Kidney International Reports. 7(11). 2462–2473. 3 indexed citations
10.
Savani, Malvi, et al.. (2021). Pegylated liposomal doxorubicin-induced renal toxicity in retroperitoneal liposarcoma: a case report and literature review. Cancer Chemotherapy and Pharmacology. 87(2). 289–294. 12 indexed citations
11.
12.
Zhou, Yan, Paari Murugan, Faqian Li, & Lihong Bu. (2021). Needle tract seeding in renal tumor biopsies: experience from a single institution. Diagnostic Pathology. 16(1). 43–43. 7 indexed citations
13.
Hanna, Christian, Loren P. Herrera Hernandez, Lihong Bu, et al.. (2021). IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine. Kidney International. 100(3). 705–706. 46 indexed citations
14.
Edlow, Brian L., Emi Takahashi, Ona Wu, et al.. (2012). Neuroanatomic Connectivity of the Human Ascending Arousal System Critical to Consciousness and Its Disorders. Journal of Neuropathology & Experimental Neurology. 71(6). 531–546. 337 indexed citations
15.
Li, Shihong, Zhaohui Jin, Samir Koirala, et al.. (2008). GPR56 Regulates Pial Basement Membrane Integrity and Cortical Lamination. Journal of Neuroscience. 28(22). 5817–5826. 176 indexed citations
16.
Jin, Zhaohui, Ian Tietjen, Lihong Bu, et al.. (2007). Disease-associated mutations affect GPR56 protein trafficking and cell surface expression. Human Molecular Genetics. 16(16). 1972–1985. 101 indexed citations
17.
Bu, Lihong & Edwin D. Lephart. (2007). AVPV neurons containing estrogen receptor-beta in adult male rats are influenced by soy isoflavones. BMC Neuroscience. 8(1). 13–13. 12 indexed citations
18.
Bu, Lihong & Edwin D. Lephart. (2006). Regulatory Behavior and Skin Temperature in Mid-Aged Male Rats on Three Different Isoflavone-Containing Diets. Journal of Medicinal Food. 9(4). 567–571. 5 indexed citations
19.
Bu, Lihong, Kenneth D.R. Setchell, & Edwin D. Lephart. (2005). Influences of dietary soy isoflavones on metabolism but not nociception and stress hormone responses in ovariectomized female rats. Reproductive Biology and Endocrinology. 3(1). 58–58. 25 indexed citations
20.
Bu, Lihong & Edwin D. Lephart. (2005). Soy isoflavones modulate the expression of BAD and neuron-specific beta III tubulin in male rat brain. Neuroscience Letters. 385(2). 153–157. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph Plehm Breakdown of academic impact, for papers by Yangmei Chen Breakdown of academic impact, for papers by E Pedersen Breakdown of academic impact, for papers by Johann Gross Breakdown of academic impact, for papers by Yasushi Miyagi Breakdown of academic impact, for papers by Isao Araki Breakdown of academic impact, for papers by Gerald Ponath Breakdown of academic impact, for papers by Kenjiro Tanaka Breakdown of academic impact, for papers by Elise Belaïdi Breakdown of academic impact, for papers by Kyoung‐Gyu Choi
Rankless by CCL
2026